首页 > 市场调查报告书 > 医疗设备

透析机设备

市场调查报告书

商品编码

1937923

全球连续性肾臟替代疗法（CRRT）市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Continuous Renal Replacement Therapy Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: 2026年02月05日 | 出版商:

Value Market Research | 英文 172 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

预计连续性肾臟替代疗法 (CRRT) 市场规模将从 2025 年的 23.4 亿美元增长到 2034 年的 47 亿美元，2026 年至 2034 年的复合年增长率为 8.07%。

随着急性肾损伤（AKI）和慢性肾臟病（CKD）在全球范围内的发病率持续上升，连续性肾臟替代疗法（CRRT）市场预计将迎来显着增长。 CRRT是治疗方法严重肾功能障碍患者的关键手段，它提供持续且温和的透析，以维持体液和电解质平衡。糖尿病和高血压等肾臟疾病的主要危险因素，其发病率的不断上升正在推动对CRRT解决方案的需求。此外，人口老化以及需要肾臟支持的严重病患数量的增加，也进一步加速了市场扩张。

技术创新在塑造CRRT市场未来中发挥关键作用。透析设备的创新，包括改进的过滤技术和人性化的介面，正在提高CRRT治疗的效率和效果。此外，远距监测和远端医疗解决方案的整合使医疗服务提供者能够更有效地管理CRRT治疗，从而确保改善患者的治疗效果。随着製造商持续加大研发投入，预计CRRT市场将在包括医院和门诊诊所在内的各种医疗机构中得到更广泛的应用。

此外，CRRT市场也受到以病人为中心的照护和个人化医疗日益重视的影响。随着医疗服务提供者寻求根据患者的个人需求量身定制治疗方案，对能够提供可自订设置和治疗通讯协定的CRRT系统的需求日益增长。这一趋势正在推动能够适应患者特定需求的先进CRRT解决方案的开发，从而改善整体治疗效果。随着市场的不断发展，技术、个人化和病人参与的整合将是成功的关键。

区域分析
北美市场分析、洞察与预测
- 我们
- 加拿大
- 墨西哥
欧洲市场分析、洞察与预测
- 英国
- 法国
- 德国
- 义大利
- 俄罗斯
- 其他欧洲国家
亚太市场分析、洞察与预测
- 印度
- 日本
- 韩国
- 澳洲
- 东南亚
- 其他亚太国家
拉丁美洲市场分析、洞察与预测
- 巴西
- 阿根廷
- 秘鲁
- 智利
- 其他拉丁美洲国家
中东和非洲市场分析、洞察与预测
- 沙乌地阿拉伯
- UAE
- 以色列
- 南非
- 其他中东和非洲国家

第九章竞争情势

最新趋势
公司分类
供应链和销售管道合作伙伴（根据现有资讯）
市场占有率和市场定位分析（基于现有资讯）
供应商格局（基于现有资讯）
策略规划

第十章：公司简介

主要公司的市占率分析
公司简介
- Fresenius Medical Care AG & Co. KGaA
- Baxter International Inc
- B. Braun Melsungen AG
- Nipro Corporation
- Asahi Kasei Corporation
- Medtronic
- DaVita Inc
- NxStage MedicalInc
- Toray Medical Company Limited
- Astellas Pharma Inc
- CytoSorbents Corp
- Infomed SA
- Medica SPA
- Medical Components Inc
- Medites Pharma Spol. SRO

简介目录

Product Code: VMR11218337

The Continuous Renal Replacement Therapy Market size is expected to reach USD 4.70 Billion in 2034 from USD 2.34 Billion (2025) growing at a CAGR of 8.07% during 2026-2034.

The Continuous Renal Replacement Therapy (CRRT) Market is poised for significant growth as the prevalence of acute kidney injury (AKI) and chronic kidney disease (CKD) continues to rise globally. CRRT is a vital treatment modality for patients with severe renal impairment, providing continuous and gentle dialysis to maintain fluid and electrolyte balance. The increasing incidence of conditions such as diabetes and hypertension, which are major risk factors for kidney disease, is driving demand for CRRT solutions. Additionally, the growing aging population and the rising number of critically ill patients requiring renal support are further propelling market expansion.

Technological advancements are playing a crucial role in shaping the future of the CRRT market. Innovations in dialysis machines, including improved filtration technologies and user-friendly interfaces, are enhancing the efficiency and effectiveness of CRRT treatments. Furthermore, the integration of remote monitoring and telehealth solutions is enabling healthcare providers to manage CRRT therapies more effectively, ensuring better patient outcomes. As manufacturers continue to invest in research and development, the CRRT market is likely to see increased adoption across various healthcare settings, including hospitals and outpatient clinics.

Moreover, the growing emphasis on patient-centered care and personalized medicine is influencing the CRRT market. As healthcare providers seek to tailor treatments to individual patient needs, there is a rising demand for CRRT systems that offer customizable settings and treatment protocols. This trend is driving the development of advanced CRRT solutions that can adapt to the specific requirements of patients, improving overall treatment efficacy. As the market continues to evolve, the integration of technology, personalization, and patient engagement will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Mode

Slow Continuous Ultrafiltration (SCUF)
Continuous Venovenous Hemofiltration (CVVHF)
Continuous Venovenous Haemodialysis (CVVHD)
Continuous Venovenous Hemodiafiltration (CVVHDF)

By Product

Dialysates And Replacement Fluids
Disposables
Systems

By Therapy

Renal
Non-renal
Combination

By End User

Hospitals
Clinics
Others

COMPANIES PROFILED

Fresenius Medical Care AG Co KGaA, Baxter International Inc, B Braun Melsungen AG, Nipro Corporation, Asahi Kasei Corporation, Medtronic, DaVita Inc, NxStage Medical, Inc, Toray Medical Company Limited, Astellas Pharma Inc, CytoSorbents Corp, Infomed SA, Medica SPA, Medical Components Inc, Medites Pharma spol sro

We can customise the report as per your requriements

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET: BY MODE 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Mode
4.2. Slow Continuous Ultrafiltration (SCUF) Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Continuous Venovenous Hemofiltration (CVVHF) Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. Continuous Venovenous Haemodialysis (CVVHD) Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.5. Continuous Venovenous Hemodiafiltration (CVVHDF) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET: BY PRODUCT 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Product
5.2. Dialysates And Replacement Fluids Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Disposables Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET: BY THERAPY 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast Therapy
6.2. Renal Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Non-renal Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Combination Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET: BY END USER 2022-2034 (USD MN)

7.1. Market Analysis, Insights and Forecast End User
7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET: BY REGION 2022-2034(USD MN)

8.1. Regional Outlook
8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Mode
- 8.2.2 By Product
- 8.2.3 By Therapy
- 8.2.4 By End User
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Mode
- 8.3.2 By Product
- 8.3.3 By Therapy
- 8.3.4 By End User
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Mode
- 8.4.2 By Product
- 8.4.3 By Therapy
- 8.4.4 By End User
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Mode
- 8.5.2 By Product
- 8.5.3 By Therapy
- 8.5.4 By End User
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 South East Asia
- 8.5.10 Rest of Latin America
8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Mode
- 8.6.2 By Product
- 8.6.3 By Therapy
- 8.6.4 By End User
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

9.1. Recent Developments
9.2. Company Categorization
9.3. Supply Chain & Channel Partners (based on availability)
9.4. Market Share & Positioning Analysis (based on availability)
9.5. Vendor Landscape (based on availability)
9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Company Profiles
- 10.2.1 Fresenius Medical Care AG & Co. KGaA
- 10.2.2 Baxter International Inc
- 10.2.3 B. Braun Melsungen AG
- 10.2.4 Nipro Corporation
- 10.2.5 Asahi Kasei Corporation
- 10.2.6 Medtronic
- 10.2.7 DaVita Inc
- 10.2.8 NxStage MedicalInc
- 10.2.9 Toray Medical Company Limited
- 10.2.10 Astellas Pharma Inc
- 10.2.11 CytoSorbents Corp
- 10.2.12 Infomed SA
- 10.2.13 Medica SPA
- 10.2.14 Medical Components Inc
- 10.2.15 Medites Pharma Spol. S.R.O

02-2729-4219

+886-2-2729-4219

License/价格

全球连续性肾臟替代疗法（CRRT）市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Continuous Renal Replacement Therapy Market Size, Share, Trends & Growth Analysis Report 2026-2034

目录

第一章引言

第二章执行摘要

第三章市场变数、趋势与框架

第四章全球连续性肾臟替代疗法（CRRT）市场依模式划分

5. 全球连续性肾臟替代疗法 (CRRT) 产品市场

6. 全球连续性肾臟替代疗法 (CRRT) 市场

7. 全球连续性肾臟替代疗法 (CRRT) 市场（按最终用户划分）

8. 全球连续性肾臟替代疗法 (CRRT) 市场（按地区划分）